Loading...
Back to narrative

ANRG: New Waste-To-Energy Contract Will Drive Stronger Future Profitability

Major Contracts And Projects Will Expand European And North American Bioenergy

ANRG logo
ANRG
AnalystConsensusTarget
Not Invested
Published 18 May 2025

Update shared on 09 Dec 2025

Fair value Increased 1.67%
Previous
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
245.0%
7D
17.9%

Analysts have modestly raised their price target on Anaergia to reflect improved expectations for revenue growth and profit margins. They now value the stock at approximately 5.08 dollars per share versus the prior 5.00 dollars, while also incorporating a slightly lower discount rate and a more conservative future price to earnings multiple.

What's in the News

  • Anaergia Technologies LLC wins a CAD 43.8 million design build contract from the East County Advanced Water Purification Joint Powers Authority in San Diego to deliver a turnkey renewable power generation facility that will convert organic waste into energy, with completion targeted within two years (Key Developments).
  • The Ontario Superior Court of Justice grants leave and certifies a class action alleging secondary market misrepresentation related to Anaergia’s June 2021 IPO and April 2022 secondary offering, with SMK Law representing investors and formal notice to follow by further court order (Key Developments).

Valuation Changes

  • The fair value estimate has risen slightly to approximately 5.08 dollars per share from 5.00 dollars per share, reflecting modestly improved expectations.
  • The discount rate has edged down marginally from about 6.35 percent to 6.32 percent, modestly boosting the present value of projected cash flows.
  • The revenue growth assumption has increased meaningfully from roughly 25.5 percent to 34.6 percent, indicating stronger anticipated top line expansion.
  • The net profit margin forecast has improved slightly from about 4.83 percent to 5.01 percent, implying modestly better operating leverage.
  • The future P/E multiple has fallen significantly from roughly 75.6 times to 60.0 times, indicating a more conservative valuation framework despite higher growth assumptions.

Have other thoughts on Anaergia?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.